Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 222, pseudogene (RNU6-222P) is a non-coding RNA gene classified as a pseudogene of the U6 small nuclear RNA (snRNA) gene family. Pseudogenes like RNU6-222P generally result from gene duplication or retrotransposition events and typically do not encode functional products. U6 snRNA is a core component of the spliceosome, mediating pre-mRNA splicing, but RNU6-222P itself is not known to be functional or serve as a protein or therapeutic target[1][4]. There are no known disease associations, drug interactions, or established biomarker roles for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 222, pseudogene (RNU6-222P).